These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 6177259)

  • 1. Identification of distinct antigenic determinants on dengue-2 virus using monoclonal antibodies.
    Gentry MK; Henchal EA; McCown JM; Brandt WE; Dalrymple JM
    Am J Trop Med Hyg; 1982 May; 31(3 Pt 1):548-55. PubMed ID: 6177259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Monoclonal antibodies to dengue virus 4: the spectrum of the reactivity to 4 serotypes of dengue].
    Pupo Antúnez M; Alvarez Vera M; Soto Hernández M; Rodríguez Sánchez H; Rodríguez Díaz R; Morier Díaz L; Guzmán Tirado MG
    Rev Cubana Med Trop; 2000; 52(2):119-25. PubMed ID: 11107906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic and polypeptide structure of turkey enteric coronaviruses as defined by monoclonal antibodies.
    Dea S; Tijssen P
    J Gen Virol; 1989 Jul; 70 ( Pt 7)():1725-41. PubMed ID: 2472464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence.
    Henchal EA; Gentry MK; McCown JM; Brandt WE
    Am J Trop Med Hyg; 1982 Jul; 31(4):830-6. PubMed ID: 6285749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic interactions of anti-NS1 monoclonal antibodies protect passively immunized mice from lethal challenge with dengue 2 virus.
    Henchal EA; Henchal LS; Schlesinger JJ
    J Gen Virol; 1988 Aug; 69 ( Pt 8)():2101-7. PubMed ID: 3404125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection enhancement of dengue type 2 virus in the U-937 human monocyte cell line by antibodies to flavivirus cross-reactive determinants.
    Brandt WE; McCown JM; Gentry MK; Russell PK
    Infect Immun; 1982 Jun; 36(3):1036-41. PubMed ID: 6284641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic analysis of Japanese encephalitis virus by using monoclonal antibodies.
    Kobayashi Y; Hasegawa H; Oyama T; Tamai T; Kusaba T
    Infect Immun; 1984 Apr; 44(1):117-23. PubMed ID: 6200438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica.
    Roehrig JT; Bolin RA; Kelly RG
    Virology; 1998 Jul; 246(2):317-28. PubMed ID: 9657950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of infection enhancement of dengue 2 strains by monoclonal antibodies.
    Halstead SB; Venkateshan CN; Gentry MK; Larsen LK
    J Immunol; 1984 Mar; 132(3):1529-32. PubMed ID: 6607288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies raised to the dengue-2 virus (Cuban: A15 strain) which recognize viral structural proteins.
    Pupo-Antúnez M; Rodríguez H; Vázquez S; Vilaseca JC; Alvarez M; Otero A; Guzmán G
    Hybridoma; 1997 Aug; 16(4):347-53. PubMed ID: 9309425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic analysis of Punta Toro virus and identification of protective determinants with monoclonal antibodies.
    Pifat DY; Osterling MC; Smith JF
    Virology; 1988 Dec; 167(2):442-50. PubMed ID: 2462308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and characterization of monoclonal antibodies directed against five structural components of human respiratory syncytial virus subgroup B.
    Orvell C; Norrby E; Mufson MA
    J Gen Virol; 1987 Dec; 68 ( Pt 12)():3125-35. PubMed ID: 2447224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dengue 4 virus monoclonal antibodies identify epitopes that mediate immune infection enhancement of dengue 2 viruses.
    Morens DM; Venkateshan CN; Halstead SB
    J Gen Virol; 1987 Jan; 68 ( Pt 1)():91-8. PubMed ID: 2433388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monoclonal antibodies to the Japanese encephalitis virus in ascitic hybridoma preparations].
    Deriabin PG; Loginova NV; Lebedeva GA; Novokhatskiĭ AS; Malakhova IV
    Antibiot Med Biotekhnol; 1986 Jan; 31(1):24-8. PubMed ID: 3947048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus.
    Gromowski GD; Barrett AD
    Virology; 2007 Sep; 366(2):349-60. PubMed ID: 17719070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chimpanzee Fab fragments and a derived humanized immunoglobulin G1 antibody that efficiently cross-neutralize dengue type 1 and type 2 viruses.
    Goncalvez AP; Men R; Wernly C; Purcell RH; Lai CJ
    J Virol; 2004 Dec; 78(23):12910-8. PubMed ID: 15542643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The reactions of monoclonal antibodies with structural proteins of mumps virus.
    Orvell C
    J Immunol; 1984 May; 132(5):2622-9. PubMed ID: 6201553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of functional epitopes on the dengue 2 envelope (E) protein using monoclonal IgM antibodies.
    Jianmin Z; Linn ML; Bulich R; Gentry MK; Aaskov JG
    Arch Virol; 1995; 140(5):899-913. PubMed ID: 7541621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenic analysis of dengue virus using monoclonal antibodies.
    Young PR
    Southeast Asian J Trop Med Public Health; 1990 Dec; 21(4):646-51. PubMed ID: 2098930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies to human cytomegalovirus: three surface membrane proteins with unique immunological and electrophoretic properties specify cross-reactive determinants.
    Pereira L; Hoffman M; Gallo D; Cremer N
    Infect Immun; 1982 Jun; 36(3):924-32. PubMed ID: 6178693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.